Recording of the webinar ‘How are costs and medicine effectiveness part of decision-making in medicine access?' given by Frederick Thielen, PhD, Assistant Professor, Erasmus School of Health Policy and Management, Erasmus University Rotterdam.
The webinar was held as part of the Horizon Europe ASCERTAIN, an EU funded project working to promote access to medicines through the development of open access policy tools, including pricing and value assessment models.
The webinar was held as part of the Horizon Europe ASCERTAIN, an EU funded project working to promote access to medicines through the development of open access policy tools, including pricing and value assessment models.
-
ASCERTAIN webinar | How are costs and medicine effectiveness part of decision-making in access?
-
MPE webinar Myeloma and infection
-
European Young Myeloma Patients Group | Latest developments in treatments for young myeloma patients
-
MPE Webinar | EHA 2025 highlights
-
MPE webinar | Living well with AL amyloidosis
-
Webinar | ‘How do different countries make decisions on reimbursing new medicines?’
-
Webinar EYMPG | Myeloma and physical fitness
-
MPE webinar: ASH 2024 myeloma and AL amyloidosis highlights
-
Webinar EYMPG | Importance of good nutrition and healthy diet for young myeloma patients
-
MPE webinar | Disease and treatment specificities for young myeloma patients
-
MPE Webinar | EHA 2024 myeloma highlights
-
MPE and ALAN webinar | Patient and clinician involvement in the EU HTA regulation